A team of researchers have found a powerful antibody produced by the immune system that blocks HIV infection by targeting VIV2, a site on the virus, according to The clinical trial of the experimental HIV vaccine has fairly succeeded among people and the analysis of the result suggests that antibodies within VIV2 sites are protective.
http://ift.tt/1fBTR13
http://ift.tt/1fBTR13
No comments:
Post a Comment